Abstract:
Background: Urinary tract infections (UTIs) are a major public health concern related to antimicrobial resistance (AMR). Women with urogenital fistula are at increased risk of complicated UTIs and infection with antimicrobial-resistant bacteria, including extended-spectrum β-lactamase (ESBL)-producing bacteria; however, comparative data among women with and without urogenital fistula in Ethiopia are limited.
Objective: This study aimed to compare the bacteriological and antimicrobial resistance profiles, ESBL production, and associated factors of UTI between urogenital fistula & non-fistula patients in Bahir Dar Hamlin Fistula Center and Felege Hiwot Comprehensive Specialized Hospital.
Methods: A comparative cross-sectional study was conducted between February and June 2026 among 105 catheterized patients (35 with fistula, 70 without fistula). Urine samples collected from catheter ports were analyzed for bacterial identification and AST using the Kirby-Bauer disk diffusion method per CLSI 2025 guidelines. ESBL production was confirmed by the combined disk method. Significant bacteriuria was defined as ≥〖10〗^3 " CFU/mL" . Data were entered using EpiData and analyzed with SPSS 26, with Statistical significance set at p <0.05.
Result: Among women with obstetric fistula, 97.1% had vesicovaginal fistula (VVF). Overall, UTI prevalence was 35.2% (95% CI: 26.8-44.8%), being significantly higher among fistula patients, 71.4% (95% CI: 54.9-83.7%), than non-fistula patients, 17.1% (95% CI: 10.1-27.6%), p < 0.001. Gram-negative bacilli predominated (86.5%), led by E. coli (43.2%) and K. pneumoniae (16.2%). All bacterial isolates from fistula patients were multidrug-resistant (MDR) compared to 75% of isolates from non-fistula patients. ESBL production was confirmed in 43% of Enterobacteriaceae isolates, predominantly E. coli (46.6%). Multivariable logistic regression identified urogenital fistula, AOR = 6.42, p = 0.041; illiteracy, AOR = 9.25, p = 0.032; and history of UTIs, AOR = 3.78, p = 0.040, as independent predictors of UTI.
Conclusion: Fistula patients face an exceptionally high UTI burden with MDR bacteria compared to non-fistula patients. Mandatory urine culture screening and targeted antimicrobial stewardship must be integrated into routine clinical protocols for fistula care.